{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:23:11Z","timestamp":1782271391347,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0191-8","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T18:02:13Z","timestamp":1417284133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis"],"prefix":"10.1186","volume":"9","author":[{"given":"Vincent","family":"Grobost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chahera","family":"Khouatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Lazor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,30]]},"reference":[{"key":"191_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1749-6632.1986.tb18541.x","volume":"465","author":"AJ Hance","year":"1986","unstructured":"Hance AJ, Basset F, Saumon G, Danel C, Valeyre D, Battesti JP, Chretien J, Georges R: Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci. 1986, 465: 643-656. 10.1111\/j.1749-6632.1986.tb18541.x.","journal-title":"Ann N Y Acad Sci"},{"key":"191_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2169\/internalmedicine.40.998","volume":"40","author":"R Watanabe","year":"2001","unstructured":"Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T: Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med. 2001, 40: 998-1003. 10.2169\/internalmedicine.40.998.","journal-title":"Intern Med"},{"key":"191_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ: Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010, 116: 1919-1923. 10.1182\/blood-2010-04-279083.","journal-title":"Blood"},{"issue":"10","key":"191_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","volume":"124","author":"NA Brown","year":"2014","unstructured":"Brown NA, Furtado LV, Betz BL, Kiel MJ, Weigelin HC, Lim MS, Elenitoba-Johnson KS: High prevalence of somatic MAP2K1 mutations in BRAF V600E negative Langerhans cell histiocytosis. Blood. 2014, 124 (10): 1655-1658. 10.1182\/blood-2014-05-577361.","journal-title":"Blood"},{"key":"191_CR5","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","volume":"123","author":"DS Nelson","year":"2014","unstructured":"Nelson DS, Quispel W, Badalian-Very G, Van Halteren AG, van den Bos C, Bovee JV, Tian SY, Van Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ: Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood. 2014, 123: 3152-3155. 10.1182\/blood-2013-06-511139.","journal-title":"Blood"},{"key":"191_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20130977","volume":"211","author":"ML Berres","year":"2014","unstructured":"Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrao M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE: BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014, 211: 669-683. 10.1084\/jem.20130977.","journal-title":"J Exp Med"},{"key":"191_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1378\/chest.98.3.765","volume":"98","author":"S Von Essen","year":"1990","unstructured":"Von Essen S, West W, Sitorius M, Rennard SI: Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest. 1990, 98: 765-767. 10.1378\/chest.98.3.765.","journal-title":"Chest"},{"key":"191_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1378\/chest.115.5.1452","volume":"115","author":"N Mogulkoc","year":"1999","unstructured":"Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ: Pulmonary Langerhans\u2019 cell histiocytosis: radiologic resolution following smoking cessation. Chest. 1999, 115: 1452-1455. 10.1378\/chest.115.5.1452.","journal-title":"Chest"},{"key":"191_CR9","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1164\/ajrccm.157.6.9709026","volume":"157","author":"A Tazi","year":"1998","unstructured":"Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ: Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 1998, 157: 2007-2010. 10.1164\/ajrccm.157.6.9709026.","journal-title":"Am J Respir Crit Care Med"},{"key":"191_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-7-16","volume":"7","author":"HS Suri","year":"2012","unstructured":"Suri HS, Yi ES, Nowakowski GS, Vassallo R: Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis. 2012, 7: 16-10.1186\/1750-1172-7-16.","journal-title":"Orphanet J Rare Dis"},{"key":"191_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1172\/JCI114865","volume":"86","author":"CJ Carrera","year":"1990","unstructured":"Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA: Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. J Clin Invest. 1990, 86: 1480-1488. 10.1172\/JCI114865.","journal-title":"J Clin Invest"},{"key":"191_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM199309023291013","volume":"329","author":"A Saven","year":"1993","unstructured":"Saven A, Figueroa ML, Piro LD, Rosenblatt JD: 2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med. 1993, 329: 734-735. 10.1056\/NEJM199309023291013.","journal-title":"N Engl J Med"},{"key":"191_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/(SICI)1096-911X(199710)29:4<288::AID-MPO9>3.0.CO;2-I","volume":"29","author":"KC Stine","year":"1997","unstructured":"Stine KC, Saylors RL, Williams LL, Becton DL: 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol. 1997, 29: 288-292. 10.1002\/(SICI)1096-911X(199710)29:4<288::AID-MPO9>3.0.CO;2-I.","journal-title":"Med Pediatr Oncol"},{"key":"191_CR14","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood.V93.12.4125","volume":"93","author":"A Saven","year":"1999","unstructured":"Saven A, Burian C: Cladribine activity in adult langerhans-cell histiocytosis. Blood. 1999, 93: 4125-4130.","journal-title":"Blood"},{"key":"191_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4065\/78.3.301","volume":"78","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Phyliky RL, Li CY, Tefferi A: 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc. 2003, 78: 301-306. 10.4065\/78.3.301.","journal-title":"Mayo Clin Proc"},{"key":"191_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/thx.2008.108944","volume":"64","author":"R Lazor","year":"2009","unstructured":"Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF: Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax. 2009, 64: 274-275. 10.1136\/thx.2008.108944.","journal-title":"Thorax"},{"key":"191_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.rmed.2007.09.002","volume":"102","author":"MR Aerni","year":"2008","unstructured":"Aerni MR, Aubry MC, Myers JL, Vassallo R: Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med. 2008, 102: 316-319. 10.1016\/j.rmed.2007.09.002.","journal-title":"Respir Med"},{"key":"191_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1440-1843.2003.00427.x","volume":"8","author":"NS Goh","year":"2003","unstructured":"Goh NS, McDonald CE, MacGregor DP, Pretto JJ, Brodie GN: Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology. 2003, 8: 91-94. 10.1046\/j.1440-1843.2003.00427.x.","journal-title":"Respirology"},{"key":"191_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1164\/ajrccm.186.9.930","volume":"186","author":"G Lorillon","year":"2012","unstructured":"Lorillon G, Bergeron A, Detourmignies L, Jouneau S, Wallaert B, Frija J, Tazi A: Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2012, 186: 930-932. 10.1164\/ajrccm.186.9.930.","journal-title":"Am J Respir Crit Care Med"},{"key":"191_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1164\/ajrccm.162.1.9906010","volume":"162","author":"P Soler","year":"2000","unstructured":"Soler P, Bergeron A, Kambouchner M, Groussard O, Brauner M, Grenier P, Crestani B, Mal H, Tazi A, Battesti JP, Loiseau P, Valeyre D: Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis?. Am J Respir Crit Care Med. 2000, 162: 264-270. 10.1164\/ajrccm.162.1.9906010.","journal-title":"Am J Respir Crit Care Med"},{"key":"191_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1378\/chest.08-1899","volume":"135","author":"BJ Krajicek","year":"2009","unstructured":"Krajicek BJ, Ryu JH, Hartman TE, Lowe VJ, Vassallo R: Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest. 2009, 135: 1542-1549. 10.1378\/chest.08-1899.","journal-title":"Chest"},{"key":"191_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1378\/chest.111.4.1142-a","volume":"112","author":"S Harari","year":"1997","unstructured":"Harari S, Brenot F, Barberis M, Simmoneau G: Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension. Chest. 1997, 112: 1142-1144.","journal-title":"Chest"},{"key":"191_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1164\/ajrccm.161.1.9807024","volume":"161","author":"M Fartoukh","year":"2000","unstructured":"Fartoukh M, Humbert M, Capron F, Maitre S, Parent F, Le Gall C, Sitbon O, Herve P, Duroux P, Simonneau G: Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000, 161: 216-223. 10.1164\/ajrccm.161.1.9807024.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0191-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0191-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:37:08Z","timestamp":1630564628000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0191-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,30]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0191-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,30]]},"assertion":[{"value":"2 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"191"}}